MedPath

Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)

Completed
Conditions
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome)
Registration Number
NCT00214773
Lead Sponsor
BioMarin Pharmaceutical
Brief Summary

The objectives of this program are: to further characterize the natural progression of MPS VI disease; to generate and disseminate information on the care and management of MPS VI patients to clinical and medical professionals; to provide a resource to physicians and patients by providing information for optimizing patient care based on aggregate data; to characterize the clinical response to long-term Naglazyme® (galsulfase) treatment; to further characterize the long-term safety of Naglazyme® treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
237
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To further characterize the natural progression of MPS VI disease, irrespective of treatment modality and to evaluate efficacy and safety treatment with Galsulfase.at least 15 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (50)

University of California, Irvine

🇺🇸

Irvine, California, United States

Children's Hospital of Los Angeles

🇺🇸

Los Angeles, California, United States

Children's Hospital and Research Center Oakland

🇺🇸

Oakland, California, United States

Emory University

🇺🇸

Decatur, Georgia, United States

Ann and Robert H. Lurie Children's Hospital of Chicago

🇺🇸

Chicago, Illinois, United States

Indiana University School of Medicine

🇺🇸

Indianapolis, Indiana, United States

Baton Rouge Clinic

🇺🇸

Baton Rouge, Louisiana, United States

Tulane University Medical Center

🇺🇸

New Orleans, Louisiana, United States

Johns Hopkins Univeristy School of Medicine

🇺🇸

Baltimore, Maryland, United States

Children's Health Care

🇺🇸

Minneapolis, Minnesota, United States

Scroll for more (40 remaining)
University of California, Irvine
🇺🇸Irvine, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.